GSK Asks Again For Dismissal Of Wellbutrin IP Claims
GlaxoSmithKline PLC has asked a judge to reconsider its request to dismiss direct purchaser claims in a class action over the drugmaker's alleged filing of baseless patent suits to delay generic...To view the full article, register now.
Already a subscriber? Click here to view full article